Abstract: The present invention relates to novel agonistic anti-TrkB antibodies and therapeutic and diagnostic methods and compositions for using the same.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Abstract: A communication method includes executing a cyclic block permutation for a codeword generated based on a quasi-cyclic parity-check code including a repeat-accumulate quasi-cyclic low-density parity-check code, where the cyclic block permutation is permutation of cyclic blocks within the codeword, and mapping each bit of the codeword for which the cyclic block permutation is executed to any one of constellation point of a non-uniform constellation.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Abstract: A load cell includes a bearing element configured for a hoist that includes a hook, a suspension with an orifice that receives a shaft of the hook, a nut, and housing. The bearing element, preferably a ring, contacts the suspension, and has an orifice that receives the shaft therethrough with the nut secured to the shaft proximate to the bearing element. Strain gauges are mounted on the ring side wall being equally spaced. A second suspension orifice concentric with the first orifice receives the ring with strain gauges therein. For improved accuracy, a thrust roller bearing and two thrust washers are positioned on sides of the ring, all of which are preferably positioned in a cup member that is received in the second orifice. A clearance fit is provided with respect to each of protruding upper and lower overhanging cylindrical ring lips and the cup to protect the gauges.

Abstract: A system for recognizing an operating intention at an operating unit that can be actuated manually includes an image capture unit for monitoring a capture region surrounding the operating unit for an entering hand in order to capture it in terms of a positioning of a palm of a hand or of one or a plurality of fingers in relation to the operating unit and to generate corresponding image information. An evaluation unit is provided for comparing the generated image information with at least one image pattern that is characteristic for an operating intention from a pattern memory. In the event of a correspondence that lies within a permitted variation range, a controllable function is enabled on the part of the operating unit.

Abstract: A beverage bottle handling system designed to handle beverage bottles and similar containers, and which includes a beverage bottle inspection arrangement to be connected to a rotatable transport star.

Abstract: A system for recognizing an operating intention at an operating unit that can be actuated manually includes an image capture unit for monitoring a capture region surrounding the operating unit for an entering hand in order to capture it in terms of a positioning of a palm of a hand or of one or a plurality of fingers in relation to the operating unit and to generate corresponding image information. An evaluation unit is provided for comparing the generated image information with at least one image pattern that is characteristic for an operating intention from a pattern memory. In the event of a correspondence that lies within a permitted variation range, a controllable function is enabled on the part of the operating unit.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Abstract: A beverage bottle checking arrangement is designed to check beverage bottles in a beverage bottle handling arrangement. The beverage bottle checking arrangement includes a single framework and checking devices mounted on the framework, which checking devices are designed to essentially simultaneously check characteristics of beverage bottles being moved through or past the framework.

Abstract: An apparatus and method for tracking defects in sheet materials. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. § 1.72(b). As stated in 37 C.F.R. § 1.72(b): A brief abstract of the technical disclosure in the specification must commence on a separate sheet, preferably following the claims, under the heading “Abstract of the Disclosure.” The purpose of the abstract is to enable the Patent and Trademark Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure. The abstract shall not be used for interpreting the scope of the claims. Therefore, any statements made relating to the abstract are not intended to limit the claims in any manner and should not be interpreted as limiting the claims in any manner.

Abstract: An apparatus and method for tracking defects in sheet materials. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. § 1.72(b). As stated in 37 C.F.R. § 1.72(b): A brief abstract of the technical disclosure in the specification must commence on a separate sheet, preferably following the claims, under the heading “Abstract of the Disclosure.” The purpose of the abstract is to enable the Patent and Trademark Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure. The abstract shall not be used for interpreting the scope of the claims. Therefore, any statements made relating to the abstract are not intended to limit the claims in any manner and should not be interpreted as limiting the claims in any manner.

Abstract: The present application relates to a tracking arrangement for the tracking of a material defect in a sheet material, such as a container material or a product-packaging material. The tracking arrangement may comprise a defect sensor, which is configured to detect a material defect in a sheet material moving thereby or therethrough. The tracking arrangement may also comprise a first structure sensor, which is configured to detect at least one inherent structural feature of the sheet material itself in the region of the material defect, as well as a control arrangement, which is configured to receive data from said first structure sensor.

Abstract: An inspection device for inspecting screw-closures on bottles includes a rotationally-symmetric lens disposed above a bottle's screw-closure and having a convex portion and a flat aspheric portion, a first lighting-unit for illuminating the screw-closure, and a camera located above the lens and connected to an image processor.

Abstract: An inspection device for inspecting screw-closures on bottles includes a rotationally-symmetric lens disposed above a bottle's screw-closure and having a convex portion and a flat aspheric portion, a first lighting-unit for illuminating the screw-closure, and a camera located above the lens and connected to an image processor.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Abstract: A device and method for identifying an object at least partially covered by a transparent material. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. §1.72(b). As stated in 37 C.F.R. §1.72(b): A brief abstract of the technical disclosure in the specification must commence on a separate sheet, preferably following the claims, under the heading “Abstract of the Disclosure.” The purpose of the abstract is to enable the Patent and Trademark Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure. The abstract shall not be used for interpreting the scope of the claims. Therefore, any statements made relating to the abstract are not intended to limit the claims in any manner and should not be interpreted as limiting the claims in any manner.

Abstract: A beverage bottle transport device in a beverage bottling plant. The abstract of the disclosure is submitted herewith as required by 37 C.F.R. §1.72(b). As stated in 37 C.F.R. §1.72(b): A brief abstract of the technical disclosure in the specification must commence on a separate sheet, preferably following the claims, under the heading “Abstract of the Disclosure.” The purpose of the abstract is to enable the Patent and Trademark Office and the public generally to determine quickly from a cursory inspection the nature and gist of the technical disclosure. The abstract shall not be used for interpreting the scope of the claims. Therefore, any statements made relating to the abstract are not intended to limit the claims in any manner and should not be interpreted as limiting the claims in any manner.

Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.